CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...
Miami, Florida, United States and 37 other locations
and with darolutamide in men with metastatic castration-resistant prostate cancer. The study aims to assess whether the drug is saf ...
Phase 1
Miami, Florida, United States and 12 other locations
The aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer...
Phase 3
Miami, Florida, United States of America and 26 other locations
Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...
Phase 3
Miami, Florida, United States and 42 other locations
The purpose of this study is to evaluate the safety, efficacy, tolerability, and pharmacokinetics (PK) of FG-3246, a cluster of differentiation 46 (C...
Phase 2
Hialeah, Florida, United States and 12 other locations
radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...
Phase 3
Fort Lauderdale, Florida, United States and 72 other locations
The main purpose of the study is to assess the safety and tolerability of AZD2284, AZD2287, and AZD2275.
Phase 1
Miami, Florida, United States and 14 other locations
The purpose of this research study is to test the efficacy of ADT on prostate-specific membrane antigen (PSMA), a marker of prostate...
Phase 2
Miami, Florida, United States
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Hollywood, Florida, United States and 112 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Hialeah, Florida, United States and 326 other locations
Clinical trials
Research sites
Resources
Legal